UTAH MEDICAL PRODUCTS (UTMD) insider trading
Insider activity, historical context and SEC filings · data through Oct 29, 2026
Insiders put their own money in: $67K of open-market buys. See how similar setups did below.
Label: Net buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Purchase Kevin L Cornwell, CEO, Chair bought 1,000 shares at $66.75 ($67K).
- Trade date
- Oct 29, 2026
- Disclosed to the SEC
- Oct 29, 2026
- Type
- Open-market purchase (code P)
Read the original SEC filing ↗All UTMD insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
Similar past setups: not applicable. There aren't enough comparable past cases for UTMD's latest buying to report odds. When insiders buy, this section shows how 16,899 similar past buys did over 90 days. How we calculate this →
Play with UTMD in the Research Lab
Pre-set to UTMD's latest insider buy of $10K or more (Oct 29, 2026: Kevin L Cornwell, $67K). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 16,899 past insider buys did.
Share price and insider trades
Price history unavailable.
UTAH MEDICAL PRODUCTS insider trading at a glance (Oct 29, 2026): in the past 12 months, 1 insider bought $67K and 0 sold $0 of UTMD stock on the open market.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings · How we calculate this
UTMD insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | $67K | 1 | — | 0 |
Valuation, profit and volume
Valuation figures for UTMD are refreshed each weekday; some aren't published for every company. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 1 UTAH MEDICAL PRODUCTS INC insider reported open-market purchases totaling $67K, while 0 insiders reported sales totaling $0.
What happened after UTMD insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| Oct 29, 2026 | Kevin L CornwellCEO, Chair | $67K | pending | pending | pending |
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 29 NewSEC | Kevin L CornwellCEO, Chair | Buy | 1,000189,472 held (+1%) | $66.75 | $67K | — | — |
Insiders at UTAH MEDICAL PRODUCTS INC
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Kevin L CornwellCEO, Chair | $67K | — | Oct 29, 2026 | — | — |
UTMD stock: common questions
Are UTAH MEDICAL PRODUCTS INC insiders buying UTMD stock?
In the past 12 months, 1 insiders reported open-market purchases of UTMD worth $67K. The latest was CEO, Chair Kevin L Cornwell bought $67K of UTMD at $66.75 — first open-market purchase in our records.
Are UTAH MEDICAL PRODUCTS INC insiders selling UTMD stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.